Literature DB >> 9386032

Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up.

A Loft1, O Lidegaard, A Tabor.   

Abstract

OBJECTIVE: To estimate the risk of developing ovarian cancer after abdominal (total or subtotal) hysterectomy on benign indication.
DESIGN: Prospective historical cohort study with 12.5 years of follow up.
SETTING: Denmark, nationwide. POPULATION: All Danish women (aged 0 to 99 years) having undergone hysterectomy with conservation of at least one ovary for a benign indication from 1977 to 1981 (n = 22,135). Follow up was conducted from 1977 to 1991. The reference group included all Danish women who had not undergone hysterectomy, age-standardised according to the hysterectomy group (n = 2,554,872).
METHODS: Registry data derived from the Danish National Register of Patients (diagnoses and operation codes) and the Civil Registration System (information about general population, including time of death). MAIN OUTCOME MEASURES: Incidence rate of ovarian cancer, lifetime risk of ovarian cancer, relative risk of ovarian cancer.
RESULTS: Seventy-one women developed ovarian cancer on average 7.0 years after hysterectomy and 10,659 women in the reference group had ovarian cancer diagnosed after on average 6.4 years. The incidence rate of ovarian cancer was 0.27 per 1000 person-years in the group that had undergone hysterectomy and 0.34 per 1000 person-years in the general population (age-standardised). The extrapolated lifetime risk of developing ovarian cancer was 2.1% after hysterectomy and 2.7% in the general population (RR 0.78; 95% CI 0.60-0.96).
CONCLUSIONS: The risk of ovarian cancer is lower among women who have undergone hysterectomy compared with those who have not. The protection seems to decrease with time.

Entities:  

Mesh:

Year:  1997        PMID: 9386032     DOI: 10.1111/j.1471-0528.1997.tb10978.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  9 in total

1.  The Appraisement of Antioxidant and Oxidant Status in Women Undergoing Surgical Menopause.

Authors:  Avneet Kaur; Pooja Negi; Veena Sarna; Rajendra Prasad; Bir S Chavan; Anita Malhotra; Gurjit Kaur
Journal:  Indian J Clin Biochem       Date:  2016-06-28

2.  Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.

Authors:  Lilah Khoja; Rachel Palmieri Weber; Penelope M Webb; Susan J Jordan; Aruna Muthukumar; Jenny Chang-Claude; Renée T Fortner; Allan Jensen; Susanne K Kjaer; Harvey Risch; Jennifer Anne Doherty; Holly R Harris; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Andrew Berchuck; Joellen M Schildkraut; Daniel Cramer; Kathryn L Terry; Hoda Anton-Culver; Argyrios Ziogas; Minh Tung Phung; Gillian E Hanley; Anna H Wu; Bhramar Mukherjee; Karen McLean; Kathleen Cho; Malcolm C Pike; Celeste Leigh Pearce; Alice W Lee
Journal:  Gynecol Oncol       Date:  2021-11-12       Impact factor: 5.304

Review 3.  Oophorectomy: the debate between ovarian conservation and elective oophorectomy.

Authors:  Elisabeth A Erekson; Deanna K Martin; Elena S Ratner
Journal:  Menopause       Date:  2013-01       Impact factor: 2.953

Review 4.  The cell of origin of ovarian epithelial tumours.

Authors:  Louis Dubeau
Journal:  Lancet Oncol       Date:  2008-12       Impact factor: 41.316

5.  C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).

Authors:  Eva Lundin; Laure Dossus; Tess Clendenen; Vittorio Krogh; Kjell Grankvist; Marianne Wulff; Sabina Sieri; Alan A Arslan; Per Lenner; Franco Berrino; Goran Hallmans; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Annekatrin Lukanova
Journal:  Cancer Causes Control       Date:  2009-03-20       Impact factor: 2.506

Review 6.  C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysis.

Authors:  Jing Li; Xuedan Jiao; Zhongfu Yuan; Haifeng Qiu; Ruixia Guo
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Prior uterine myoma and risk of ovarian cancer: a population-based case-control study.

Authors:  Jenn Jhy Tseng; Chun Che Huang; Hsiu Yin Chiang; Yi Huei Chen; Ching Heng Lin
Journal:  J Gynecol Oncol       Date:  2019-09       Impact factor: 4.401

8.  Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis.

Authors:  Megan S Rice; Megan A Murphy; Shelley S Tworoger
Journal:  J Ovarian Res       Date:  2012-05-15       Impact factor: 4.234

9.  Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial.

Authors:  Keith Y Terada; Hyeong Jun Ahn; Bruce Kessel
Journal:  J Gynecol Oncol       Date:  2016-05       Impact factor: 4.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.